Mentorship for improving treatment of opioid use disorder and HIV in marginalized groups
Official title: Mentorship in research on opioid use disorder, HIV and marginalized populations
Funded at Albert Einstein College of Medicine · NIH-10901838 · Data updated 2026-11-12
This study is looking for new ways to help people who inject drugs and are at risk for opioid use disorder and HIV get the care they need, while also training new researchers to improve health outcomes for these communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | August 15, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $184,804 |
| NIH project number | 5K24DA057873-02 |
| Project ID | NIH-10901838 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from marginalized communities who are at risk for or currently experiencing opioid use disorder and HIV.
✕Less likely to help
Patients who do not belong to marginalized populations or who do not have opioid use disorder or HIV may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the treatment and prevention of opioid use disorder (OUD) and HIV among marginalized populations, particularly people who inject drugs (PWID). It aims to develop innovative approaches to engage these high-risk groups in evidence-based care. The project involves mentoring early-stage investigators to improve their research skills and understanding of drug policy, ultimately leading to better health outcomes for affected individuals. The research is supported by a strong institutional framework that includes clinical trials and community-based interventions.
Why it matters
Potential benefit: If successful, this research could lead to improved access to effective treatments for opioid use disorder and HIV prevention among marginalized populations.
How similar studies have gone: Previous research has shown success in similar mentorship and intervention approaches aimed at improving health outcomes for marginalized populations.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Fox, Aaron D — Albert Einstein College of Medicine
- Study coordinator: Fox, Aaron D
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.